InvestorsObserver
×
News Home

Do Traders Think Kronos Bio Inc (KRON) Can Keep Climbing Friday?

Friday, March 08, 2024 12:34 PM | InvestorsObserver Analysts

Mentioned in this article

Do Traders Think Kronos Bio Inc (KRON) Can Keep Climbing Friday?

Kronos Bio Inc (KRON) stock is higher by 32.35% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Sentiment Score - ,bullish
Kronos Bio Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on KRON!

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With KRON Stock Today?

Kronos Bio Inc (KRON) stock is higher by 4.65% while the S&P 500 is down -0.08% as of 12:28 PM on Friday, Mar 8. KRON has risen $0.06 from the previous closing price of $1.29 on volume of 731,498 shares. Over the past year the S&P 500 is higher by 29.09% while KRON is down -18.67%. KRON lost -$2.08 per share in the over the last 12 months.

More About Kronos Bio Inc

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription. Click Here to get the full Stock Report for Kronos Bio Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App